Speaker Details
Jack Jacobs
President
Zhittya Genesis Medicine Inc.
About
Dr. Jack Jacobs is president of Zhittya Genesis, a biopharmaceutical company developing a biological drug which triggers angiogenesis and neurogenesis. He leads the company's efforts to obtain FDA approval for its drug to treat Parkinson's Disease, ALS, Alzheimer's, multiple sclerosis, and enhance stroke recovery.
Content from Jack Jacobs
Disease Reversal with Pharmaceutical Angiogenesis: New Therapies for Stroke, Parkinson's Disease, and More
10/17/2019 12:00 am EST
...
Frontiers of Regenerative Medicine: Disease Reversal with Angiogenesis
10/07/2019 12:00 am EST
New regenerative biopharmaceutical products are now under clinical development to stimulate the body...